论文信息 - 11q Deletion (del11q) Is Not a Prognostic Factor for Adverse Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Ibrutinib: Pooled Data from 3 Randomized Phase 3 Studies - 字舞流文

11q Deletion (del11q) Is Not a Prognostic Factor for Adverse Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Ibrutinib: Pooled Data from 3 Randomized Phase 3 Studies

J. Byrd | U. Jaeger | T. Kipps | M. Hallek | A. Chanan-Khan | A. Howes | S. Stilgenbauer | S. O'brien | G. Fraser | S. Coutre | P. Barr | P. Cramer | P. Hillmen | F. Demirkan | A. Janssens | M. Cheng | J. Barrientos | C. Phelps | S. Grosicki | J. Ninomoto | D. James | M. Salman | I. Solman